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EXECUTIVE SUMMARY
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Capstone Project, University of Northern Colorado, 2019.

Cervical cancer screening has evolved throughout the years into the current,
very effective, algorithms for screening and management. The success of improved
early detection of cervical cancer has saved many lives (Lees, Erickson, & Huh,
2016). The addition of human papillomavirus testing and genotyping has allowed for
more efficient, and less invasive, management of cervical cancer screening (Cox,
2009). While there are significant advantages to these new guidelines, there are
barriers to applying them in practice. The clinical site for the project was identified to
be in need of a quality improvement project aimed at creating an improved patient
notification, tracking and reminder system as well as improving provider adherence
with the evidence-based guidelines. There were 48 total eligible providers that were
included in the project.
After identification of the problem, a review of the literature was undertaken to
identify an evidence-based strategy for addressing practice gaps. This literature review
focused on provider guideline adherence with cervical cancer screening guidelines and
patient notification, tracking and reminder systems. Current literature demonstrates a
gap in provider guideline adherence nationwide as well as strategies aimed at
improving both provider and patient adherence with the reccomendations. These
iii

include use of consistent patient notification processes, implementation of an
electronic tracking and reminder system, and provider educational sessions aimed at
improving guideline compliance. Donabedian’s (2005) quality improvement
framework was utilized to divide the literature findings into those interventions that
effect outcomes, structure, and process of care in order to form the project plan and
methods.
Following this in-depth look at the background and existing literature, the
project plan was established. The plan consisted of two phases: the first focusing on
creation of project materials and preparation for project implementation, and the
second focusing on the roll out of the new process and data collection for project
analysis. Two objectives were identified for this project: improve provider adherence
to the 2012 American Society of Colposcopy and Cervical Pathology Guidelines and
implementation of an electronic patient notification, tracking and reminder system. A
plan for data collection and analysis through pre- and post-implementation provider
surveys and chart audits was established.
After project implementation, data collection and analysis occurred. Objective
One was evaluated in order to determine if the project implementation correlated with
an increase in provider guideline adherence. The quality improvement project did find
an improvement in guideline adherence in recommending appropriate follow-up for
patients following receipt of cervical cancer screening results. For their survey
responses on a series of patient vignettes, as well as whether patients were actually
screened at an appropriate interval according to the recommendations, the providers
were not found to show a statistical improvement following implementation of the
project. In evaluating Objective Two, there was found to be moderate compliance on
iv

the part of the providers with the new process in the weeks following project
implementation. Nursing participants in the new process were found to be 100%
compliant with following the process. No statistical difference was found in provider
beliefs regarding the practice’s tracking and reminder system pre- and postintervention. Limitations existed in this study that limit the ability of the researcher to
make assumptions based on the findings. Regardless, this project served to address the
need for a robust notification tracking and reminder system. This system helps to
ensure that patients receive timely, clear, and concise communication regarding their
cervical cancer screening results and what these results mean for them. Additionally,
they are notified and reminded to follow-up as needed. This is all done in an attempt to
continue to drive down cervical cancer rates while also reducing unnecessary, and
costly, procedures and testing.
Keywords: cervical cancer screening, guideline adherence, tracking and
reminder systems, patient notification of results
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CHAPTER I
INTRODUCTION
Cervical cancer was, at one time, undetectable until it had progressed to the point
that survival was unlikely and treatment options were few (Centers for Disease Control
and Prevention, 2017). Research on methods of early detection have led to evidencebased guidelines for the screening and management of cervical cancer. While these
guidelines and screening options have reduced mortality associated with this type of
cancer, they are complex and difficult for providers and practices to adhere to. Chapter I
serves to introduce the background and significance of this problem and the purpose of
the Doctor of Nursing Practice (DNP) scholarly project.
Background and Significance
Invasive cervical cancer was once the leading cause of cancer-related death in
women (Centers for Disease Control and Prevention, 2017). In an effort to find a way to
detect cervical cancer early, Dr. George Papanicolaou began researching cervical and
vaginal sampling in the 1920s (Lees, Erickson, & Huh, 2016). He developed and
established the screening test now known as the Pap test and published his research in
1941 (Lees et al., 2016). As practitioners began adopting the Pap test routinely and
annual screening became mainstream, cervical cancer death rates began to fall. During
the years of 1950 to 1970, mortality rates dropped an astonishing 3% per year (Lees et
al., 2016).
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The Pap test began as a method of screening in which a sample of cells is taken
from the cervix and placed on a slide for microscopic evaluation (Lees et al., 2016). It has
since evolved to what is known today as liquid cervical cytology, in which the sample is
placed in a preservative liquid and then is sent for pathology evaluation (Lippincott
Procedures, 2017). The cells are observed for any changes that could be precancerous and
are evaluated for maturity, morphology, and metabolic activity (Lippincott Procedures,
2017). These results are then sent to the provider noting the presence, if any, of abnormal
cells as well as type of cell that is found. The type of abnormal cell noted helps the
provider determine which risk category the patient falls into and to determine future
follow-up. Despite the success of annual cervical cytology testing, the test itself was
found to be a poor predictor of future cervical cancer (Lees et al., 2016). Pap testing has
been identified to have a specificity of 98% with a sensitivity of only 51% (Lees et al.,
2016). To account for its high false negative rate, annual screening was necessary in
order to continue to drive down cervical cancer rates (Lees et al., 2016).
In an effort to identify improved screening practices, scientists began
investigating the causes of the dysplastic changes that were occurring in cells, and in
1976 a causative effect between infection with the virus human papillomavirus (HPV)
and dysplastic changes in cervical cells was found (Cox, 2009). In 1983, Dr. Harald zur
Hausen isolated the high-risk HPV strain, HPV 16 and later HPV 18, which are now
known as the strains that account for up to 70% of cases of cervical cancer (Lees et al.,
2016). Twelve additional high-risk strains have since been identified, adding up to a total
of 14 strains that are tested for in current high-risk HPV testing (Lees et al., 2016).
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Once HPV was identified to be the cause of cervical cancer development, the
focus shifted to determining what this meant for screening guidelines. In the late 1980s,
there were two simultaneous landmark studies done that investigated the role of HPV
testing in routine screening (Cox, 2009). Once the Food and Drug Administration
approved the first test for HPV, ViraPap, it was used in a trial in conjunction with repeat
Pap and colposcopy in patients who had been referred to colposcopy following abnormal
Pap results at a student health center (Cox, 2009). Of the 482 patients who had been
referred for colposcopy, only 262 (54%) would have required colposcopy using the
criteria of either a positive HPV test or abnormal cytology instead of the presence of
atypical cells alone (Cox, 2009). For study participants with an abnormal finding of
atypical squamous cells of undetermined significance, using HPV testing to determine the
need for colposcopy would have further reduced the total procedures necessary to 178 of
the original 482 (37%), while still maintaining a clinically low rate of missing cervical
intra-epithelial neoplasia (Cox, 2009). At the completion of Cox’s study, it was identified
that HPV testing could be used in conjunction with Pap testing, referred to as co-testing,
to safely determine whether colposcopy is necessary (Cox, 2009).
While HPV has been exclusively linked to cervical cancer, not all HPV infections
lead to cancer and many do not need to be treated. Up to 90% of HPV infections will
clear spontaneously within one to two years of initial infection (Lees et al., 2016). The
HPV infections that persist or that are associated with certain cervical cytology changes
now allow providers to use past screening results in conjunction with current results to
place patients into risk categories and determine appropriate follow-up based on level of
risk (Lees et al., 2016). The current American Society for Colposcopy and Cervical
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Pathology (ASCCP) guidelines are based on these factors, among others, and give a
thorough, yet complicated, series of follow-up and routine screening recommendations.
The use of co-testing, cervical cytology combined with high-risk HPV testing,
was first implemented into the algorithm for the management of atypical squamous cells
of undetermined significance (ASC-US) (Cox, 2009). This category of results was the
most common abnormal finding from Pap testing and led to a high number of
unnecessary colposcopies that resulted in normal findings (Cox, 2009). On the other side
of this issue, ASC-US is associated with a higher risk of future development of cervical
intraepithelial neoplasia, leaving providers in need of a way to determine which patients
with a finding of ASC-US required further evaluation (Cox, 2009). Further research
supported using HPV testing to triage ASC-US results into those who required treatment
and those who were likely to resolve without intervention (Cox, 2009). In 2012, both the
ASCCP as well as the American College of Obstetrics and Gynecologists released
guidelines incorporating HPV genotyping into the long-standing solitary Pap testing
guidelines and decreased the frequency of screenings for certain low risk groups (Cox,
2009).
The advantages of these new guidelines were significant: fewer and more targeted
screenings without fear of increased numbers of late stage cervical cancer. The
savings associated with these new guidelines might not only be in healthcare
expenditures, but in the time spent on unnecessary screening in an era where
widespread shortages of primary care providers exist. (Boone, Lewis, & Karp,
2016, p. 261)
Emerging research is focusing on the role of high-risk HPV testing alone as primary
screening (Lees et al., 2016). In 2014, the United States Food and Drug Administration
approved the first HPV genotyping test for primary screening of cervical cancer in
women 25 years or older (Baker, 2017). The ASCCP, among other organizations,
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released amended guidelines that allowed for the option of HPV genotyping alone for
routine screening in certain populations (Baker, 2017). Many countries around the world
have already made the move to fully utilize primary HPV testing to screen the population
either for all patients or for certain populations based on age and geographical location
(Baker, 2017). These include the Netherlands, Denmark, Sweden, and Italy (Baker,
2017). Additionally, the discovery and manufacture of the HPV vaccine that vaccinates
against several strains of HPV, including the high-risk HPV 16 and HPV 18, pose further
questions about the future of HPV and cervical cancer screening (Lees et al., 2016) (see
Appendix A for a Cervical Cancer Screening Timeline).
If properly followed, the guidelines present an evidence-based approach to
screening that limits unnecessary procedures while maintaining a low risk of missing
invasive cervical cancer. The increased intervals in the guidelines are to allow for the
transient nature of HPV infection and reduce the risks of over screening, with the primary
risk being unnecessary procedures such as colposcopies (Cox, 2009). A literature review
of 16 studies regarding psychological after effects of colposcopy found that there is an
increased risk of psychological distress, particularly anxiety, following colposcopy
(O’Connor et al., 2015). An additional study done in Ireland found that four out of five
respondents reported experiencing at least one negative physical after affect, either
bleeding, pain, or discharge, at a four-month questionnaire following colposcopy
(O’Connor et al., 2015). Proper adherence to the guidelines reduces the risks associated
with unnecessary procedures for patients in addition to reducing the cost, both time and
money, for patients and providers (Boone et al., 2016).
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In the face of rapidly changing evidence on which to base practice, there have
been many changes to screening in primary care. The current set of algorithms, while
evidence-based and scientifically shown to improve outcomes, are complicated and rely
on a series of information, including prior cervical cytology and genotyping, in order to
determine an appropriate follow-up recommendation. In addition to a complex system of
determining follow-up care, there are cultural factors that influence a lack of adherence
with the guidelines including fear of litigation and management of patient perceptions
(Teoh et al., 2015). Finally, the move from an easy to manage system of annual screening
to a myriad of follow-up options ranging from several weeks to five years with a variety
of follow-up procedures necessary has led to providers, and practices as a whole,
struggling to establish a notification, tracking and reminder system that will improve
compliance with the recommended follow-up for both providers and patients (Dupuis et
al., 2010).
Problem Statement
In a primary care organization, there was a need identified for a quality
improvement project regarding cervical cancer screening. The current state was a manual
tracking and reminder system for the whole practice and an opportunity for improvement
in provider guideline adherence. A quality improvement project was necessary in order to
assess the current state of guideline adherence and implement interventions to address
any gaps identified as well as to create an improved patient notification, tracking and
reminder system following screening. The problem, intervention, comparison outcome
question was:
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Q

For providers in a primary care practice, does implementation of an
educational session in conjunction with an electronic patient notification,
tracking and reminder system, as compared to the usual care and tracking
system in use, increase adherence to the 2012 American Society for
Colposcopy and Cervical Pathology cervical cancer screening guidelines?
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CHAPTER II
REVIEW OF THE LITERATURE
The literature review was divided into two categories: provider guideline
adherence and patient notification, tracking and reminder systems (see Appendix B for
the literature review matrix). Databases searched included Cumulative Index of Nursing
and Allied Health Literature, Cochrane, Google Scholar, and PubMed databases. Articles
found were rated by level of evidence as noted in the literature review table (Melnyk &
Fineout-Overholt, 2015). This section is a synthesis of the literature review by category.
Provider Compliance with Recommendations
Search terms for this section of the literature review included guideline adherence
and cervical cancer screening guideline adherence. The original search found over
400,000 articles. The modifiers of provider, full text available, and earliest publication
date of 2007 were added to narrow the search. Articles that focused on patient
compliance components and those that focused on adherence to older versions of the
guidelines were excluded. Additionally, research that focused solely on adherence by
providers who specialize in gynecology were excluded as the population for this quality
improvement study is a primary care practice. Over 100 articles were reviewed in total.
Of those, eight were included in the final literature review. A summary of these findings
is included below.
In 2013, a cross sectional survey of 124 providers found that overall compliance
with the guidelines was poor. Of these, 15 indicated that they were not aware that the
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guidelines had changed. Sixty-three providers reported that they always comply with the
new guidelines; however, of those only seven were able to correctly answer all of the
knowledge-based questions on the survey. This indicates a knowledge and practice gap
between what the evidence supports and what is actually happening in practice. Providers
who indicated that they were not following the guidelines indicated reasons why. The
most commonly cited reasons for disregarding the guidelines included fear of litigation
and that their patients were demanding a different interval. The authors summarized:
“adherence rates are only moderate within a single health care maintenance organization
and are likely even lower in the wider health care community” (Teoh et al., 2015, p. 8).
An additional survey-based study, conducted in 2014 in Indiana, reflected similar
concerns with guideline adherence. The survey used in this study was vignette-based, and
findings indicated that providers were compliant with recommendations regarding when
to start and stop screening. Non-compliance was found when looking at the
recommended intervals for screening of those in the 21- to 65-year age range. In this
study, only 18 (16.2%) of the 111 providers who responded appropriately followed the
guidelines for all patient vignettes provided. In the 21- to 29-year age range 81% of
providers responded with an incorrect screening interval, one that most closely aligned
with the 1988 guidelines, out of date by 26 years at the time of this study. No correlation
was found between age, gender, years in practice, and number of Pap smears performed
per week and compliance with the guidelines. Reasons most commonly cited by
providers in this survey for not adhering to the guidelines included concern for lack of
follow-up and patient expectations (King, Kasper, Daggy, & Edmonds, 2014).
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The largest and most current survey-based study found during the review of the
literature was conducted in 2016. Nearly 5,000 surveys were sent in California with 1,268
respondents. Of these providers, 35% reported that they felt the guidelines were not
clinically appropriate. Of those who did report finding the guidelines appropriate and that
they were using them, only 15.3% were able to accurately recommend screening intervals
for all patient scenarios given. This survey found that there were providers who were
inappropriately screening women less than 21 years of age, over screening by frequency
and use of HPV co-testing in the 21 to 30 age range, continuing co-testing every three
years over the age of 30 when the recommendation is every five years, and 33% of
providers reported continuing to screen those over the age of 65(Boone et al., 2016).
In 2015, another survey-based study was conducted that aimed to evaluate the reasons
behind poor guideline adherence. Concerns offered by survey respondents regarding less
frequent screening, as recommended in the guidelines, were given. Thirty six percent of
providers who were not following the guidelines named patient concern about the
guidelines as their primary reason for not following. Other reasons given were health
system quality measures that use different criteria, not agreeing with the guidelines, risk
of malpractice, and inadequate time to have a risk versus benefit discussion with their
patients regarding screening (Haas et al., 2015).
In addition to research regarding provider adherence to the guidelines and reasons
behind the poor adherence, the literature review discovered research regarding
interventions to improve adherence. In Temple, Texas, at Baylor, Scott & White, a large
primary care practice, a study assessed the impact of implementing both a provider
education and embedded point-of-care reminders in an electronic health record (EHR) for
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cervical cancer screening guidelines was completed (Langsjoen et al., 2015). The aim of
this study was to specifically look at compliance with ordering HPV co-testing for those
over the age of 30. The authors found that their intervention had little effect on the
practices of providers who specialized in gynecology but that they were already highly
compliant with guidelines. For family practice providers, however, “Epic (the EHR) and
a training session had minimal impact on compliance with ordering HPV cotesting at the
time of a Pap smear except among family practice physicians, who did significantly
improve their compliance rate” (Langsjoen et al., 2015, p. 453).
The EHRs have supplied the opportunity for a new approach to increasing
adherence with routine screening and care. This approach is in the form of point-of-care
reminders for providers (Shojania et al., 2011). These point-of-care reminder systems are
designed to help providers determine what their patients are due for during their visits
and help to increase the likelihood that proper follow-up and screening are done. In a
systematic review of electronic point-of-care reminder systems, it was determined that
these reminder systems do show a moderate improvement in adherence to the process
being studied (Shojania et al., 2011). While significant variability existed in the outcomes
for the studies, a median increase of 4.2% was seen in overall process adherence with the
addition of point-of-care reminders in the 28 studies included in the review (Shojania et
al., 2011). The ability to utilize electronic reminder systems embedded into the EHR is
one strategy that practices have implemented in order to give providers tools to adhere to
best practice recommendations, including those surrounding cervical cancer screening.
An additional study supports this finding that the use of the EHR over traditional
pen and paper systems has the potential to assist practices in achieving an increased
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quality of care. In 2011, a cross-sectional study was done to investigate the impact of
implementation of an EHR on quality of care in four different health screenings.
Physicians using EHRs provided significantly higher rates of recommended care
than physicians using paper for four quality measures: hemoglobin A1c testing for
patients with diabetes, breast cancer screening, chlamydia screening, and
colorectal screening. (Kern, Barron, Dhopeshwarkar, Edwards, & Kaushal, 2012,
p. 500)
Per the updated guidelines, those under the age of 21 do not require cervical
cancer screening. This is one population within the guidelines that has significantly lower
adherence than others (Lozman, Belcher, & Sloand, 2013). A small quality improvement
project was done at a pediatric primary care office. The intervention in this study was a
30-minute educational session for all eight providers at the practice on the cervical cancer
screening guidelines. Data analysis consisted of pre- and post-intervention chart reviews
comparing adherence to the guidelines before and after the education. The number of
unnecessary Pap tests done according to chart reviews in the six months prior to the
intervention was 29. In the six months following the educational session, only two
unnecessary Paps were done. “This small QI [quality improvement] project suggests that
tailored educational sessions that allow for discussion may be beneficial in improving
provider adherence to CPGs [clinical practice guidelines]” (Lozman et al., 2013, p. 586).
Notification, Tracking and Reminder Systems
The second part of the literature review focused on patient notification, tracking,
and reminder systems. The same databases as mentioned above were searched using the
terms test results notification, tracking and reminder systems, and patient notification. A
substantially lower amount of literature exists in this area. Approximately 50 articles
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were reviewed for this section and of those, eight were included in the final literature
review.
In addition to difficulty in determining appropriate screening intervals and followup, providers and practices are faced with a need for a notification, tracking and reminder
system that can manage the intricacies of clinical decision making and need for follow-up
care that accompany cervical cancer screening. Patient notification of testing results is an
important component of both quality and safety. In 2001, a report was prepared for the
Agency for Healthcare Research and Quality (AHRQ) analyzing patient safety factors.
One section of this report was in regard to critical results notifications, specifically
notification of abnormal cervical cytology results. The study referenced in this section
found that use of a form letter to notify patients was shown to decrease the amount of
patients with cervical intraepithelial neoplasia lost to follow-up from 23% of patients lost
to follow-up in the control group with standard notification practices to 0% lost to followup in the group sent the form letter (University of California at San Fransisco (UCSF)—
Stanford University Evidence-based Practice Center, 2001). According to this AHRQ
report, “One of the most distressing safety issues of the clinical encounter is the failure to
follow- up on diagnostic tests, particularly when a patient is not notified of an abnormal
result” (University of California at San Fransisco (UCSF)—Stanford University
Evidence-based Practice Center, 2001, p. 482). This was the only study the AHRQ was
able to find regarding patient notification of abnormal results that met inclusion criteria;
however, despite the lack of strong evidence regarding notification systems, it remains
necessary for practices to have systems for notification of test results. Additionally, in
2013 a study was done that examined patients’ understanding of their cervical cytology
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results and recommended follow-up (Slone et al., 2015). According to this study, as many
as 35.3% of patients misunderstood their follow-up recommendations as verbally given to
them by their provider. The EHR provides valuable tools in the realm of patient
notification; however, provider and support staff comfort with the use of the EHR
provide a limitation to its usefulness.
The (electronic medical record) EMR shows great potential to assist health care
providers in the areas of result interpretation, patient notification of test results,
and documentation of the follow-up plan; however, there must be an
understanding of the use. The clinician survey found lack of clinician confidence
in using the EMR. Increased familiarity with the functions available for test
results reporting in the EMR and increased use of these features could add
standardization, efficiency, and confidence in the test results management
process. (Sullivan & Smolowitz, 2013, p. 123)
Recommendations for patient notification systems have been discussed; however, an
important aspect of follow-up remains to be addressed. Practices and providers need a
system to track patients and remind them to follow up at an appropriate interval based on
findings of their cervical cancer screening. The American College of Obstetrics and
Gynecologists (2012) published a committee opinion entitled, Tracking and Reminder
Systems, that speaks to the concerns around failures that can occur in ineffective systems:
Failure to follow up may cause delayed or missed diagnoses or treatment, which
may result in an adverse patient outcome and potential liability for the health care
provider. Failure to follow up on laboratory results has been identified as one of
the leading causes of lawsuits in the outpatient setting. (p. 1)
Electronic health records open the door to more efficient tracking systems than the pen
and paper systems that existed prior to the wide spread use of EHRs. Researchers at the
Boston University School of Medicine implemented a quality improvement process in
which they embedded a patient tracking system into their EHR (Dupuis et al., 2010).
Following implementation of this program, they were able to decrease their mean time to
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diagnostic resolution of all abnormal results over a two-year period from 108 days to 86
days (Dupuis et al., 2010). An additional study done at the University of Minnesota
implemented a centralized tracking system for cervical cancer screening results.
Following implementation of this EHR-based system, the system saw a 63.86% reduction
in unnecessary Pap smears done in patients less than 21 years old (Teoh, Fall,
Beitelspacher, & Lais, 2012).
Despite the benefits of a patient tracking system embedded into the EHR, use of
this tool continues to fail to realize its potential. A 2013 survey-based study found that
less than half of the providers surveyed utilized the EHR to determine if patients had
completed ordered tests. In this same study, 80% of providers reported that they were
either not using the EHR to its full potential or were unsure about their use of the EHR
and whether it could be utilized more extensively (Sullivan & Smolowitz, 2013). A
reliable system for tracking and managing follow-up recommendations can serve to
improve clinical outcomes and reduce liability for healthcare organizations (The
American College of Obstetrics and Gynecologists, 2012). Furthermore, a 2016 study
found that despite increased adoption of EHRs, system support for cervical cancer
screening continued to be inadequate. This study found that only 16.4% of providers
surveyed reported having an automated system in place to notify them of patients
overdue for cervical cancer screening, and only 17.6% reported having a system in place
to track follow-up after receipt of abnormal test results (Schapira et al., 2016).
In addition to an accurate and reliable patient tracking system, practices need a
process for reminding patients to follow-up at appropriate intervals. Accurate and timely
follow-up reminders have been shown to increase patient compliance with follow-up
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recommendations (The American College of Obstetrics and Gynecologists, 2012). A
2017 Kaiser Permanente study used focus groups to assess patient preferences in terms of
follow-up reminders for cancer screenings. The researchers found that a personalized
reminder letter, sent no more than three months prior to when the patient is due for
screening, was preferred by the majority of study participants (Brandzel et al., 2017).
Theoretical Framework
The theoretical framework for this quality improvement project is Donabedian’s
quality improvement model. This model was created by physician Avedis Donabedian
and was first published in 1966 (Donabedian, 2005). Donabedian is widely renowned as
the father of quality improvement in medicine as it is known today (Ayanian & Markel,
2016). His work has been used to establish quality indicators for organizations such as
the Institute of Medicine and is one of the most frequently cited works in the public
health literature over the last 50 years (Dupuis et al., 2010). Donabedian (2005) provided
a framework of three lenses through which evaluation of quality can be performed. This
framework can be applied to the problem of cervical cancer screening guideline
adherence and provider compliance in order to assess the opportunities for improvement
and methods to address these.
The first lens that Donabedian (2005) gave to view quality through was the lens of
outcomes. Outcomes are a common way of assessing quality of care provided. They are
generally concrete, are easy to validate, and can be measured. While Donabedian
supported the power of outcomes as one method of assessing quality, he listed several
limitations to this measure as well. Among these are the relevancy of chosen outcomes,
ability to control other factors that relate to outcomes than the one being observed, and

17
length of time that needs to transpire before some outcomes can be evaluated. For the
purpose of this project, the outcomes of following the evidence-based guidelines for
screening are well substantiated and known to decrease mortality as a result of cervical
cancer (Lees et al., 2016). Additionally, establishment of patient tracking and reminder
systems have shown to increase patient compliance with follow-up recommendations
(The American College of Obstetrics and Gynecologists, 2012). Furthermore, the time
frames associated with follow-up for cervical cytology restrict the feasibility of
evaluating patient follow-up for this project. With widespread agreement on the effect of
timely evidence-based screening with appropriate follow-up, patient outcomes will not be
evaluated in this project.
The second lens that Donabedian (2005) spoke to was to evaluate the process of
how care is provided. On evaluation of process, Donabedian stated: “One is interested not
in the power of medical technology to achieve results, but in whether what is known to be
‘good’ medical care has been applied” (p. 694). This arm of quality evaluation looks at
the provider’s skill and knowledge, completeness of the physical examination,
appropriateness of further evaluation decisions, provision of appropriate preventative
care, among other factors (Donabedian, 2005). The process evaluation for this project
revealed a need for assessment of the provider’s knowledge and practice gaps and an
educational strategy aimed at addressing these.
The final lens that Donabedian (2005) gave was the lens of structure. Structure
evaluation includes reviewing the administrative, facility, and equipment factors that
affect quality. The implementation of the notification, tracking and reminder system is
aimed at addressing an identified structural gap. This system will give providers a
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convenient system for managing follow-up communication and reminders aimed at
increasing patient follow-up compliance and reducing liability of the organization
associated with ensuring proper follow-up is provided.
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CHAPTER III
METHODS
Project Plan
Following the review of the literature and an analysis of the current state, the
project plan was established. The following chapter is a review of the project plan
including the project objectives and evaluation plan, resources needed, a timeline, and an
analysis of the congruence of the project plan with the organization’s objectives. The
project plan is divided into two phases. (see Appendix C for an infographic of the project
plan).
Phase One
Phase One focused on the preparation for Go Live for the patient notification,
tracking and reminder system and gathering of pre-implementation data. A survey was
distributed to providers to assess perceived barriers to adherence as well as current
knowledge regarding the American Society for Colposcopy and Cervical Pathology
(ASCCP) guidelines (see Appendix D for a sample survey). This survey was modified
from a survey created jointly by the Agency for Healthcare Research and Quality
(AHRQ), National Cancer Institute, and Centers for Disease Control: “National Survey of
Primary Care Physicians’ Cancer Screening Recommendations and Practices” (National
Cancer Institute, 2006). The breast cancer screening questions were removed, and clinical
vignettes were updated to reflect changes in the guidelines since the survey’s creation in
2006. Additional sections were added in order to evaluate provider demographic

20
information and the structure and process components not addressed in the survey in its
original form. This survey has been modified several times by the named agency to make
it applicable to a variety of cancer screenings, thus further information regarding the
validity of the tool was not available (National Cancer Institute, 2006). The survey was
reviewed by the Doctor of Nursing Practice (DNP) project chair, physician chair on the
project committee, and medical director of the practice prior to distribution.
The modified survey contained 18 total questions and was divided into three
sections. Question types included multiple-choice, select all that apply, Likert scales, and
free text. Section A contained demographic data about the respondent. This demographic
data included information such as the provider’s age, gender, years in practice,
credentials, approximate number of patients, percentage of those patients who are female,
and average number of patients screened for cervical cancer annually. Questions in this
section included four multiple-choice questions and two free text questions. This
information was used in aggregate form for data analysis and trending.
Section B focused on evaluation of the process components of this project.
Questions were in regard to the provider’s current guideline preference, trust in the
evidence behind the guidelines, a series of patient vignettes in which the provider
indicated what the initial screening and recommended follow-up would be, and a
question regarding possible barriers to guideline adherence. One question had a Likert
scale response. Three questions were in a multiple-choice format. One question was a
select all that apply.
Section C focused on the structure component of the project and included whether
the practice had the following processes in place: patient notification of abnormal results,
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provider reminders when screening is due, patient reminders when screening is due, and a
tracking system to identify patients who have not followed up as recommended. There
was also a question regarding whether the provider used any resources to assist in
determining follow-up recommendations based on the guidelines. Four of these questions
were in a select all that apply format and one question was multiple-choice. Finally, there
was a free text section that allowed the provider to add any additional information about
cervical cancer screening that they felt was important.
The pre-implementation survey had 12 respondents of the total 48, for a 25% rate.
The post-implementation survey had 10 respondents of the total 35 eligible providers, for
a response rate of 28.5%. Upon receipt of the survey results, the responses were
evaluated to determine the current state of knowledge and compliance barriers at the
practice. An evidence-based presentation was then presented giving the history of, and
evidence behind, the guidelines as well as methods and resources for addressing any
identified barriers to guideline adherence. This presentation was customized based on the
survey results in order to best address the barriers to guideline adherence at this practice.
The provider educational session aimed to address the process component of this quality
improvement project (Donabedian, 2005) (see Appendix E for an outline of the
educational session).
Additionally, during this phase of the project, the final planning and creation of
training materials for the patient tracking and reminder system was completed that
worked to address the structure component of the quality improvement project
(Donabedian, 2005). The author worked with the electronic health record (EHR)
specialist and the medical director to establish the staff who would maintain the patient
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notification, tracking, and reminder system. A group of nurse leaders in the organization
was chosen to pilot managing the notification, tracking and reminder system and formed
what was referred to as the Pap pool.
These nurse leaders served as advisors during the creation of this process as well.
The existing reminder system, as well as the point-of-care reminder system that was
available in the EHR, was utilized for this process. Letter templates and templated
phrases were created during this phase and were embedded into the EHR for an efficient
process of notifying and reminding patients. Training was also provided to the nurses and
support staff who managed the Pap pool.
The final process that was created involved the provider indicating the findings
and the recommended follow-up and routing this note to the Pap pool in the EHR. The
Pap pool nurses who managed the pool then took the result note and notified the patient.
All abnormal results notifications occurred verbally by telephone, followed by a form
letter sent through either the patient portal or by mail. Literature on patient notifications
has identified that patients are more likely to misunderstand follow-up reccomendations
when given verbally and that the use of a form letter has been found to increase patient
compliance with the recommendations (Slone et al., 2015; University of California at San
Fransisco (UCSF)—Stanford University Evidence-based Practice Center, 2001). Patient
notification letters were created using plain language definitions of the cervical cancer
screening findings as well as the reccomended follow-up and instructions for the patient
on how to schedule the appointment or notify the practice if deciding to follow-up
elsewhere.
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Following notification of the patient, the Pap pool nurse then updated a report in
the EHR called the Pap track report. This action updated the point-of-care reminder
system embedded into the EHR. The nurse then placed a “tickler,” an electronic reminder
embedded into the EHR, for the Pap pool that would alert the month that the patient is
due to repeat their screening. In the future, when this tickler alerts the Pap pool nurse, the
nurs will then check the patient’s chart to identify if she hase completed or scheduled a
follow-up screening. If she has, the chart is closed out. If she has not, the Pap pool nurse
will send the patient a reminder letter to follow-up and set another tickler for a month out.
This reminder letter will be sent no more than a month prior to the reccomended followup, as this time frame was found in the evidence to be the most effective (Brandzel et al.,
2017). A second, and then third and final, reminder letter are then sent using the same
process before the chart is closed out.
Phase Two
During this phase, the presentation was presented to practice providers. This
presentation included education on the history of the guidelines and evidence supporting
their implementation as well as training on the use of the patient tracking and reminder
system and available EHR support and tools. (see Appendix E for an outline of the
educational session). Additionally, training for the nursing and support staff was
completed. Each clinic received the educational session and then began utilizing the new
process immediately after completion of this session.
Following implementation of these interventions, patient charts were monitored
for guideline adherence using the chart audit form that can be found in Appendix F. The
chart audit form was created by the researcher and was divided into two sections. The
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first section evaluated guideline adherence, and the second evaluated process adherence
with the new notification, tracking and reminder system. The initial pre-implementation
survey was again sent to the providers as a posttest to identify any change in perceived
barriers and any change to knowledge of proper follow-up and management using the
vignette scenarios.
Objectives
For this DNP project, the following objectives were planned: Objective One,
improve provider adherence to the 2012 ASCCP guidelines and Objective Two,
implement and evaluate an electronic patient notification, tracking and reminder system.
Objective One: Improve Provider
Adherence to the 2012 American
Society for Colposcopy and
Cervical Pathology
Guidelines
This objective was evaluated through two different data sources. The first was
through analysis of pre- and post-implementation surveys. The survey questions that were
used for evaluation of this objective were B1-5 and C3. Descriptive statistics were used
including age ranges, provider characteristics, and patient populations seen. These were
compared to overall guideline compliance to evaluate for any potential trends. The
question with the Likert scale response was evaluated and pre- and post-intervention
results were compared to determine impact. The patient scenarios were marked as correct
or incorrect based on the 2012 ASCCP recommendations and were expressed as the
percent correct and compared pre- and post-intervention. Any selections that met either
the recommended or acceptable responses as stated by the ASCCP guidelines were
marked as correct. Additionally, if any providers followed the updated 2015 guidelines
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regarding primary human papillomavirus (HPV) testing, these were marked as correct as
well (ASCCP, 2014). Question B5 regarding perceived barriers was analyzed by
percentage of providers who responded indicating each given option as a barrier to
implementation and was again compared pre- and post-intervention. Due to limited
sample size for the survey, parametric data analysis was not feasible. The Mann Whitney
U test was used to account for the small sample size in order to compare pre- and postintervention changes.
The second source of data was in the form of chart reviews (see Appendix D for
sample chart review form). A report was run on all patients who had cervical pathology
results during the six months leading up to implementation and following implementation
until the end of the data collection period. A representative 20% were reviewed to
determine whether the follow-up was congruent with the 2012 ASCCP recommendations.
Questions 1 and 2 were expressed in terms of percentage correct out of the charts
reviewed and were again compared pre and post intervention. As there was a larger
sample size for chart audits, the two-tailed t-test was used to evaluate pre- and postintervention findings.
Objective Two: Implement an
Electronic Patient Notification,
Tracking and Reminder
System
This objective was evaluated using chart audits (see Appendix F) and the survey
as well. To evaluate this, the researcher reviewed charts for adherence to the
implemented process. In order to assess the impact of this quality improvement project,
pre- and post-survey responses were also evaluated that looked at barriers to guideline
adherence. Specifically, the survey questions of C1, C-2, C4, and C5 were compared pre-
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and post-implementation in order to evaluate effectiveness of the quality improvement
project from the provider’s perspective. These questions were evaluated in terms of
percentage of providers who indicated in the affirmative that there is a process in place
for each question. Again, the Mann Whitney U test was used to compare pre- and postdata to account for the low sample size. For the chart audits for this section, there is not
comparison data for this as this is a new process that is being evaluated. Data are
presented in terms of overall adherence with the process. Questions 3 through 5 are
expressed in percentages that are completed correctly in accordance with the new
process.
Congruence with Organization Objectives
The study site was a primary care clinic with multiple office locations in northern
Colorado that was founded in the 1960s. It is structured as a patient-centered medical
home and accepts multiple private insurances as well as Medicare and Medicaid. As a
patient-centered medical home, the practice proposes that their care emphasizes
improving and maintaining healthy lifestyles through evidence-based care. Objective
One, regarding improving provider compliance with the 2012 ASCCP guidelines, aligns
closely with this statement. The guidelines are evidence-based and proper management of
cervical cancer screening helps patients strive to maintain health. The practice also
focuses on the experience of the patient seeking care there and in ensuring consistent and
thorough communication occurs. Objective Two, which focuses on the patient
notification, tracking and reminder system, aligns well with the practice’s strategy of
providing peace of mind to patients by ensuring that communication regarding their
cervical cancer screening is clear and consistently delivered.
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Timeline of Project Phases
The project proposal was approved in early spring 2018. Following successful
defense of the proposal and the University of Northern Colorado’s Institutional Review
Board approval (see Appendix G), the survey was distributed to providers in November
2018. The initial survey was given to providers with a two-week window given for
responses. At the completion of the survey cycle, the results were reviewed, and
information on evidence-based screening guidelines and available resources was
presented to practice providers using the survey results to identify areas of focus for the
quality improvement project and educational session. Two weeks following the
presentation, the same survey was sent again to providers for post-implementation
evaluation purposes.
During this timeframe, training materials were created for providers and nursing
staff. Additionally, EHR modifications were made including building dot phrases, letter
templates, and creation of an electronic nurse pool entitled the cervical cancer screening
pool, referred to in this project as the Pap pool. Following the creation of these materials,
training was provided to nursing staff during leadership meetings. Additionally, each
clinic received an educational session over the lunch hour for providers. After each office
received the provider educational session, the process went live. Following the Go Live
at each clinic, chart audits occurred. A 20% representative population of all patients with
cervical cytology ordered was audited in order to measure compliance with both the
process and the cervical cancer screening guidelines.

28
Resources
As this project focused on using resources that already existed within the system,
the resource need was low. The largest resource was the time to train staff and for their
participation in the project. The approximate time for training on the notification,
tracking and reminder system was one hour for the nurses at the clinics. The nurse
managers also met with the researchers for a total of approximately four hours to discuss
creation of the new process. The time expense for providers was a one-hour educational
and training session in addition to an estimated 30 minutes to answer both the pre- and
post-survey.
Other resources needed were support of stakeholders. These included the
practice’s medical director, nursing support staff, and the electronic health record
specialist. Additionally, there was a limited cost for copying and handouts to be provided
to the support staff and providers. Most clinics chose to provide lunch for the provider
educational session as well. The final resource needed was the time of the researcher as
well as travel back and forth to the clinical sites.
Ethical Considerations
In order to protect study participants, Institutional Review Board approval was
obtained prior to beginning any research. The largest ethical consideration with this
project was protecting the anonymity of the providers participating in the survey. Survey
participation was voluntary, and there were no repercussions for choosing not to
participate. An introduction letter (see Appendix H) and consent form were sent with
each communication regarding the survey informing participants of the purpose of the
project, nature of the survey, and notification that participation was voluntary and could
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be withdrawn at any time. The practice medical director distributed the survey link via email. All information provided in the surveys was presented in aggregate form and
contained no identifying information for the provider. All data collected from chart audits
were free of identifying information for both patients and providers, and no patient
information was stored externally outside of the EHR.
Statement of Mutual Agreement
The statement of mutual agreement designates the agreement between the practice
and the researcher regarding the project (see Appendix I for the statement of mutual
agreement).
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CHAPTER IV
RESULTS AND OUTCOMES
Following Phase I and II of the project, data collection was completed in order to
evaluate the effectiveness of the project plan related to the objectives identified. There
were two sources of data utilized for review: the provider survey and retrospective chart
audits. The chapter presents an analysis of the results and outcomes for each project
objective.
The pre-implementation survey was sent to the entire practice and had 12
respondents of the total 48 included providers for a response rate of 25%. Two providers
partially completed the survey. The partial responses were included in the data presented
up through the questions that were completed. The post-implementation survey was sent
to a representative group of six of the total nine clinics that had gone live at the time of
data collection. The post-implementation survey had 10 respondents of the total 35
included for a response rate of 28.57%. Refer to Table 1 for demographic data of both
pre- and post-intervention survey respondents.
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Table 1
Survey Respondent Demographic Data

Demographic

Surveys distributed
Surveys returned

Pre-intervention
n
%

Post-intervention
n
%

48
12

100
25

35
10

100
29

Provider type
MD/DO
PA
NP

8
4
0

67
33
0

9
1
0

90
10
0

Age
< 50
35-50
< 35

4
4
4

33
33
33

3
5
2

30
50
20

Gender
Male
Female

3
9

25
75

5
5

50
50

Years in practice
<5
5-10
10

4
0
8

33
0
67

2
2
6

20
20
60

Note. MD/DO = medical doctor/doctor of osteopathic medicine; PA = physician
assistant; NP = nurse practitioner.

Additionally, providers were asked about the populations of patients they see
including age, gender, and volume of screening they complete annually. For age of the
patient, the providers were given the options of under 18, 18 to 39, 40 to 64, and > 65 and
asked to estimate the percentage of patients in each age category that they see in practice.
A breakdown of the age distribution of patients can be seen in Table 2. For the pre-
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intervention responses, on average, 61.5% of patients seen by the providers were female
and post-intervention, 58.7% were female. Question 7 was in regard to the frequency that
cervical cancer screening was done by provider. Pre-implementation, one provider (8%),
indicated doing only one to 10 screenings annually. Two (17%) indicated that they do 11
to 20 screenings annually. The remaining nine (75%) indicated that they do > 20
screenings per year. The post-intervention survey indicated that the providers who
responded all completed > 20 screenings per year except one who indicated doing 11 to
20 screenings annually.

Table 2
Patient Age Estimation as a Percent of Whole Patient Population

Patient age

Pre-implementation
M (%)
SD

Post-implementation
M (%)
SD

< 18

19.17

5.34

19

4.96

18-39

25.42

5.19

28.13

14.38

40-64

30.83

8.37

30.63

10.5

65

22.92

10.30

21.88

12.8

The two survey distributions had similar response rates. Overall demographics
were similar as well. The post-intervention survey had a higher percentage of doctors
who responded and less Physician Assistants than the pre-intervention. There was also a
higher percentage (50%) of provider responses from those who were 35 to 50 years old
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versus the pre-intervention survey with an equal distribution in all age categories. Postintervention, survey respondents were equally divided with 50% being male and 50%
being female. The pre-intervention survey had a higher (75%) proportion of male
respondents to females (25%). Finally, the distribution for years in practice remained
with the highest percentage being > 10 pre- and post- intervention (67% and 60%,
respectively). The pre-intervention survey had no respondents in the 5 to 10-year range of
years of practice whereas the post-intervention survey had two. For patient populations
seen, the post-intervention group was very similar to the pre-intervention group for both
patient age and overall percentage of female patients seen.
The second method of data collection, chart audits, was completed on a
representative 20% of total charts for patients who had cervical cancer screening
completed during the time frame. Pre-implementation audits were collected from June 1,
2018, to December 1, 2018. Post-implementation audits were done following completion
of the roll out at a representative six of the total nine clinics in February 2019 through
March 11, 2019.
Objective One: Improve Provider Adherence to
the 2012 American Society of Colposcopy and
Cervical Pathology Guidelines
Provider Survey
For Objective One, questions B1 through B5 and C3 were evaluated.
B1. How effective do you believe the following screening procedures are in
reducing cervical cancer mortality in average-risk women? For each of the following
options, Pap test alone, human papillomavirus (HPV) genotyping with Pap test, and HPV
testing as primary screening (without Pap test), respondents were asked to indicate their
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perceived efficacy using the Likert scale options of very effective, somewhat effective,
not effective, and effectiveness not known.
Both pre- and post- intervention surveys indicated that providers, on average, felt
most confident with Pap testing with HPV co-testing. This is the testing most supported
by the guidelines. In the pre-intervention survey, 83.33% of providers indicated that they
felt this method of screening was very effective and, following the educational session,
100% of providers chose this option.
The guidelines also give options for primary HPV screening. A brief discussion of
the evidence supporting this recommendation was given in the provider educational
session. The pre-intervention survey indicated that five providers (41.67%) believe this
method of screening to be very effective, three (25%) indicated that they believe it is
somewhat effective, two (16.67%) indicated that they believe that it is not effective, and
the final two (16.67%) indicated that they did not feel the efficacy of this method of
screening was known. Following the educational session, 60% of providers responded
that they believe primary HPV testing to be very effective, and 40% responded that they
believe it to be somewhat effective. No providers chose the not effective or effectiveness
not known options.
B2. In your clinical practice which cervical cancer screening guidelines do
you follow? The majority of the providers, eight (66.67%), selected that they were
following the American Society of Colposcopy and Cervical Pathology (ASCCP)
guidelines, while two (16.67%) indicated that they were following the United States
Preventative Task Force Services guidelines. The final two (16.67%) indicated that they
were following the American College of Obstetricians and Gynecologists guidelines.
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Following the educational session, seven providers (87.5%) indicated that they were
following the ASCCP guidelines. One provider (12.5%) indicated following the United
States Preventative Task Force Services guidelines. Two did not respond to this question.
B3. Assume that the following asymptomatic female patients present for a
routine visit in your office. What would you be most likely to recommend for
cervical cancer screening at this visit? Respondents were asked to identify screening
procedure and interval. Screening procedure options: Pap, Pap + HPV testing, HPV
testing alone, none, and other: (comment). Follow-up interval options: annually, every
three years, every five years, none, and other: (comment). See Table 3 for survey findings
for this question.
The following scenarios are from the survey:
A.

An 18-year-old who had sexual intercourse for the first time one month

ago and is presenting for her first gynecologic visit: For this vignette, the correct answers
would be none for both the screening procedure and interval, as this patient should not be
screened for cervical cancer due to being under the age of 21.
B.

An 18-year-old who first had sexual intercourse three years ago and is

presenting for her first gynecologic visit: For this vignette, the correct answers would be
none for both the screening procedure and interval as well for the same reason listed
above.
C.

A 21-year-old who has received the entire HPV vaccine series: The correct

answers for this vignette are cervical cytology and every three years. Current guidelines
do not change screening intervals for patients who have been vaccinated against HPV.
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D.

A 25-year-old who has no history of abnormal Pap smears: The correct

answer for this vignette is also cervical cytology every three years.
E.

A 35-year-old who has had three consecutive negative Pap tests performed

by you: The correct answer for this vignette is co-testing (Pap and HPV testing) every
five years.
F.

A 35-year-old whose cervix was removed last year during hysterectomy

for symptomatic fibroids: The correct answer for this question would be none for both
screening test and interval as this patient has had a hysterectomy with removal of the
cervix for a non-cancer related reason.
G.

A healthy 66-year-old who has had three consecutive negative Pap tests

performed by you; the last was a co-test three years ago which was negative for HPV as
well: The correct answer for this vignette is none as screening recommendations are that
screening complete at age 65.
H.

A healthy 66-year-old who has not had routine screening for cervical

cancer since her mid-30s: This question was excluded from data analysis and from the
post-intervention survey as it did not contain the necessary option of once for the followup interval options.
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Table 3
Question B3: Screening Scenarios

Scenario
n

Pre-implementation
Correct Incorrect

n

Post-implementation
Correct Incorrect

A

12

11

1

10

10

0

B

12

11

1

10

10

0

C

12

12a

0

10

10

0

D

12

12a

0

10

10

0

E

12

10a

2

10

10

0

F

11

10

1

10

10

0

G

11

11

0

10

10

0

a

Some responses did not indicate the interval but did indicate the correct screening
method.

B4. You receive the following results on the following patients. What is your
follow-up recommendation? Respondents were asked to indicate their recommended
follow-up procedure and interval. Procedure options: repeat Pap cytology, reflex HPV
testing, Pap + HPV testing, colposcopy, and other: (comment). Interval options:
immediate, one year, every three years, and every five years.
The following scenarios are from the survey:
A.

A 21-year-old with result of atypical squamous cells of undetermined

significance (ASC-US) with no prior screening. The acceptable answers for this vignette
are reflex HPV testing immediately or repeat Pap in one year.
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B.

A 22-year-old with results of low-grade squamous intraepithelial lesion

with no prior screening. The acceptable answer for this question was a repeat Pap test in
one year. The reflex HPV test is indicated by the guidelines to be acceptable for ASC-US
only.
C.

A 25-year-old with result of ASC-US with prior negative Pap. There were

two acceptable options for this vignette: reflex HPV immediately or repeat Pap cytology
in one year.
D.

A 31-year-old with result of negative cytology and HPV, prior result low-

grade squamous intraepithelial lesion. This question was excluded from data analysis and
the post-intervention survey as the vignette did not provide the necessary information to
indicate follow-up recommendation.
E.

A 35-year-old with negative cytology but positive HPV test: HPV 16 and

18 negative. The correct follow-up for this vignette was co-testing (Pap and HPV) in one
year.
F.

A 38-year-old with low-grade squamous intraepithelial lesion and negative

HPV test. The acceptable options for this vignette are immediate colposcopy or repeat cotesting at one year.
G.

A 42-year-old with a result of ASC-US and HPV negative, prior result

cytology negative, HPV positive. The correct follow-up for this vignette would be
immediate colposcopy.
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Table 4
Question B4: Follow-up Scenarios

Scenario
n

Pre-Implementation
Correct Incorrect

n

Post-Implementation
Correct Incorrect

A

11

9

2

10

9

1

B

11

6

5

10

5

5

C

11

8

3

10

8

2

E

10

9

1

10

10

0

F

10

10

0

10

9

1

G

10

0

10

10

3

7

B5. Are you following current screening guidelines on all of your patients? If
no, why not? Options: yes, I am following current screening guidelines; no, I do not
know the current guidelines; no, I do not think guidelines are based on good data; no, I
believe I have a higher-risk population; no, my patients are requesting more frequent
screening; no, I am worried about missing high grade dysplasia or cancer in the interim;
and no, I am worried about being able to keep track of whether my patients complete
follow-up with a longer screening interval.
Prior to the implementation of the project, eight (72.73%) of the providers who
responded indicated that they are following the current guidelines. One provider (9.09%)
indicated patient preference as their reason for not following the guidelines. One provider
indicated other and noted recommending every three-year intervals for co-testing instead
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of five but did not indicate why. Following the educational session, nine (90%) of
providers indicated that they were following the guidelines. One provider indicated other
and were following the guidelines except not recommending co-testing every three years
in most women.
C3. Do you use any of the following resources for managing cervical cancer
screening in practice? Options given: printed guidelines, website, phone or tablet
application, patient handouts, other: (comment), or none of the above.
Prior to the intervention, nine providers (90%) indicated that they were using a
resource of some sort in practice. One provider indicated using printed guidelines, two
(18.18%) indicated that they use the ASCCP website, and six (54.55%) indicated that
they use the phone or tablet application created by the ASCCP. One provider indicated
that not using any resources. One provider did not answer this question. Post intervention,
all providers indicated that they were using a resource of some sort in clinical practice.
Six providers indicated that they were using the ASCCP application. Two providers
indicated that they were using the website. One provider indicated using patient handouts.
The final provider indicated using patient handouts, printed guidelines, and a reminder
system managed by clinic staff.
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Chart Audits
For Objective One, chart audits were done comparing guideline compliance preand post-intervention. A report was run to identify all clinic patients who had cervical
cytology ordered during the above mentioned six months preceding the project
implementation and following the educational session at each clinic until the completion
of the project in March 2019. For the initial, pre-intervention chart audits, there were a
total of 2,121 patients who had cervical cytology performed during the six-month
window. Of these, a representative 20% of the charts were audited for a total of 425.
Post-intervention, there were a total of 232 charts that met inclusion criteria, resulting in a
20% representative sample of 47 charts that were included in the auditing process. An
independent t-test was used to compare the pre- and post-intervention findings.
Question one: Did recommended follow-up comply with either the preferred
or acceptable options per the 2012 American Society of Colposcopy and Cervical
Pathology guidelines? For Question one, the provider’s result note in the chart was used
for the audit as well as the results of cytology and prior results, if available. The patient’s
information was input into the ASCCP tablet application, and the appropriate follow-up
was identified using all available information recorded in the patient’s chart for accuracy.
This follow-up was compared to the follow-up indicated by the provider in the result
note. The result note is completed by the provider after receiving the results indicating
that they received the results, reviewed them, and anything they would like done with the
results such as patient notification and follow-up. If the provider used either the preferred
or acceptable recommendations from the 2012 ASCCP guidelines or used primary HPV
testing as presented in the 2015 updated guidelines by the ASCCP, the recommendation
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was considered in alignment with the guidelines. Additionally, if the provider mentioned
that the patient was following a different interval due to another health condition, such as
immunocompromise, these charts were excluded from the audit. Each chart audited was
marked as either a yes, no, or not indicated. A yes indicated that the provider
recommended a follow-up interval and procedure that was in alignment with the
guidelines as indicated above. A no indicated that the recommended follow-up was not in
alignment with the guidelines, either by interval or procedure. A not indicated was used
when the provider did not indicate when or how the patient should follow up in their
result note. A two-tailed t-test was used to evaluate the pre- and post-intervention data for
this question. See Table 5 for the findings of Question one of the chart audits.

Table 5
Chart Audits: Question One

Response

Pre-intervention
(%)

Post-intervention
(%)

Difference
(%)

p value

Yes

40.71

72.34

31.63

<0.0001

No

25.18

10.64

14.54

0.0264

Not indicated

34.12

17.02

17.10

0.0176
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Question two: If available, did screening interval from last screening comply
with the 2012 American Society of Colposcopy and Cervical Pathology guidelines?
For Question two, a complete review of the necessary aspects of the chart was completed
to gather all historical information electronically available. This included the provider’s
note, past pathology results, and past result notes. This information was input into the
ASCCP tablet application to identify the recommended follow-up based on all
information available for the most recent prior available screening result. If the current
screening occurred less than 12 months either before or after the recommended follow-up
time frame, the chart audit form was recorded with a yes. If the time frame fell outside of
the 12-month allowance on either side of the recommended follow-up interval, a no was
recorded. A no was also recorded if a different type of testing or procedure was done than
what the guidelines recommended. This included use of HPV testing outside of what the
guidelines recommend. If the information available was insufficient to identify when the
patient was due for re-screening or re-testing, an unknown response was recorded. A twotailed t-test was used to evaluate data for Question two. See Table 6 for the chart audit
findings.
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Table 6
Chart Audits: Question Two

Pre-intervention
(%)

Post-intervention
(%)

Difference
(%)

Yes

39.53

40.43

0.9

0.9048

No

36.47

38.30

1.83

0.8051

Unknown

23.29

21.28

2.01

0.7566

Response

p value

Objective Two: Implement and Evaluate an Electronic
Patient Notification, Tracking and Reminder System
Provider Survey
For Objective two, questions of C1, C2, C4, and C5 and were evaluated.
C1. Does your practice have a mechanism to remind you or other members of
the care team that a patient is due for cervical cancer screening? Options given: yes,
special notation of flag in patient’s chart; yes, computer prompt or computer-generated
flow sheet; yes, I routinely look it up in the medical record at the time of a visit, yes,
other mechanism (specify), and no.
Pre-intervention, 10 providers responded to this question. Of those, six (60%)
indicated that there was a provider reminder system in place. No providers selected the
option of special notation of flag in the patient’s chart. Two (20%) selected computer
prompt or computer-generated flow sheet. Four (40%) providers indicated that they
utilize a chart review to look up the medical record for each visit. One selected other and
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indicated that there is a file system in place. Finally, three providers (30%) indicated that
there was no mechanism in place. Two providers did not answer this question.
On the post-intervention survey, all 10 providers indicated that there was a
mechanism to remind them that patients are due for screening. Eight providers (80%)
indicated that they use a chart review to identify what the patient was due for. Four
providers (40%) also indicated that there was an EHR point-of-care reminder of some
sort in their response.
C2. Does your practice have a mechanism to remind your patients that they
are due for cervical cancer screening? Options given: yes, verbal prompt from you or
another member of the care team during an office visit, yes, reminder by mail, yes,
reminder telephone call, yes, reminder by e-mail, yes, other mechanism (specify), no, and
I don’t know.
Prior to project implementation, four providers (40%) indicated that there was
some form of patient reminder system in place including telephone calls, e-mails, and
mailed notification. No providers selected the verbal prompt option. Three providers
(30%) indicated no, and one provider (10%) indicated I don’t know. Two providers did
not answer this question.
Post-implementation, seven providers (70%) indicated that there was a patient
reminder system in place. Options chosen included mailed reminders, patient portal
message, telephone call, and e-mail, all of which were included in the new reminder
process. One provider (10%) indicated that there was not a notification system in place,
and two (20%) indicated that they did not know if there was one.
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C4. Does your practice have a system to track patients who do not complete
follow-up of an abnormal screening result? Options given: yes and no.
For the pre-intervention survey results, six providers (60%) responded yes, two
providers (20%) responded no, and two providers (20%) responded I don’t know. Two
providers did not respond to this question. Following roll out of the new system, nine
providers (90%) indicated that there was a tracking system in place, and one provider
(10%) indicated that there was not.
C5. Does your practice have a mechanism to inform patients of abnormal
results? Options given: yes, letter by mail; yes, telephone call; yes, e-mail message; yes,
other method (specify); I don’t know; and no.
Prior to the roll out of the new system, all providers indicated that there was a
notification system in place and that this notification occurred via a telephone call. One
provider indicated that patient’s may also receive e-mail notification of results. One
provider selected the other option and wrote in that a letter is sent if the patient does not
answer their message. Two providers did not respond to this question. Following roll out,
all providers again indicated that there was a notification system in place. On this survey,
however, more options were chosen for how patients were notified included a telephone
call, e-mail, and mailed notification.
Chart Audits
For the chart audits for this section, there is not comparison data for this as this
was a new process that is being evaluated. Data were evaluated in terms of overall
adherence with the process. Questions three through five were expressed as percentages
that are completed correctly in accordance with the new process.
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Question one: Was a result note placed and routed to the cervical cancer screening
pool?
Question two: Was a tickler placed in the patient’s system?
Question three: Was a notification letter sent to the patient?
For all three questions, nursing compliance with the process was found to be
100%. If the provider placed the result note and routed it to the Pap pool, Questions two
and three in regard to the tickler and notification system were found to have been done
appropriately. For provider compliance with the new process, Question one, 12 of the
charts (26%) were done incorrectly and 35 of the charts (74%) were done correctly. For
Questions two and three, these percentages remained the same.
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CHAPTER V
RECCOMENDATIONS AND IMPLICATIONS
FOR PRACTICE
The purpose of this quality improvement project was to improve provider
guideline adherence through an educational system implemented alongside an updated,
evidence based notification, tracking and reminder system. Following implementation of
this project and collection of pre- and post-data, the results were evaluated to determine
the impact of the project. The following chapter serves to outline the researcher’s
recommendations and implications for practice following completion of this project.
Analysis of Findings
Objective One
The quality improvement project included data collection through two sources:
provider surveys and chart audits. For Objective One, the data collected were analyzed to
identify any trends found in provider practice as well as to identify the effectiveness of
the educational session and new cervical cancer screening management process for the
clinic in improving provider compliance with the American Society for Colposcopy and
Cervical Pathology (ASCCP) guidelines.
The first portion of analysis served to determine if a difference was found in
provider compliance by different demographic factors. There was no statistical difference
in guideline compliance for identification of appropriate screening scenarios and followup found between any of the demographic or practice population questions on the survey
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including gender of provider, type of provider, age of provider, years in practice,
percentage of female patients seen, age populations seen, or number of screenings
performed annually.
The second portion of data analysis for the survey compared pre- and postintervention findings in the context of Objective One. A shift in provider’s attitudes
towards cervical cancer screening practices was identified. Providers were 16.67% more
likely to indicate that they felt the use of human papillomavirus (HPV) testing in
conjunction with Pap testing was very effective in screening for cervical cancer. They
were also 18.33% more likely to indicate very effective when referring to primary HPV
testing, a method of screening that has strong support in the evidence but has not been
adopted widespread in practice as of yet (ASCCP, 2014). Providers were also 20.83%
more likely to indicate that they were following the ASCCP guidelines as opposed to
other guidelines that exist.
For the pre-intervention survey, 83.33% of providers were able to correctly
identify the routine screening recommendations (Survey Question B3) for all patient
scenarios given as compared to 100% of providers on the post-intervention survey. A
16.67% improvement was found in providers’ abilities to identify the correct screening
interval following the intervention. Additionally, Question B4 was used to evaluate the
provider’s guideline adherence when indicating the suggested follow-up based on the
cervical cancer screening findings. Pre-intervention, none of the providers were able to
accurately recommend follow-up according to the guidelines for all scenarios. Following
the intervention, three providers were able to correctly identify the follow-up for all of
the scenarios. This is a difference of 10.84%. The limited sample size of this survey data
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means that the Mann-Whitney U value for all data analysis exceeded that of the critical
value, meaning the researcher is unable to reject the null hypothesis based on the findings
from the research. This limits the ability of the researcher to make assumptions about the
statistical accuracy of these results.
The second source of data for the project was the chart reviews. The two
questions used in the chart review evaluated this objective according to both how the
providers indicated that they would practice as well as how that knowledge translated
into practice. Comparison of both sources of data found that this quality improvement
project did show a statistically significant improvement in how providers indicated that
they would practice and recommended follow-up screening but did not show a statistical
difference in how frequently they actually performed that follow-up.
Following the educational session and Go Live of the Pap track process, providers
were twice as likely (p = 0.0176) to have indicated what the recommended follow-up
should be in their result note following receipt of the cervical cancer screening pathology
and laboratory results. Additionally, providers were 31.63% (p < 0.0001) more likely to
not only have indicated when the patient should follow-up, but to have adhered to the
ASCCP guidelines in indicating their recommended follow-up.
While these results show a significant improvement in follow-up
recommendations made, there was found to be no statistical difference in whether the
screening performed by the provider at the current visit complied with the guidelines or
not following implementation of the project. Both pre- and post-intervention, over onethird of patients had screening done that was either too early, too late, or an inappropriate
test was chosen (36.47% and 38.30%, respectively). Providers were more likely to
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recommend that their patients follow up appropriately but were no more likely to actually
complete the screening according to the guidelines.
These findings align with research findings in the literature review. Prior to the
quality improvement project, 25% of the time the recommended follow-up on the
cervical cancer screening result was incorrect. No providers were able to correctly
identify the appropriate screening interval and appropriate follow-up for all of the
scenarios given as well. This aligns closely with findings in the literature of poor overall
guideline adherence. Research utilizing educational sessions for providers as well as use
of point-of-care reminders in the electronic health record (EHR) were found to have
shown a moderate improvement in guideline adherence (Langsjoen et al., 2015; Lozman
et al., 2013). This quality improvement project did not find this to be the case. It was not
possible within the scope of this project to evaluate the impact of the reminders that were
embedded into the EHR as these point-of-care reminders will not be utilized until the
next time the patient is due for screening. Following the educational session, there was
found to be a statistically significant improvement in guideline adherence for
recommended follow-up following receipt of screening results. While this finding
supports that the educational session and new system improved provider compliance with
the recommendations, this did not hold true for how the providers practiced before and
after the intervention. They were more likely to recommend appropriate follow-up;
however, they continued to screen either too early or too late according to the guidelines.
Facilitators. The medical director and quality director served as facilitators for
this objective. They assisted the researcher in developing educational materials as well as
promoting provider engagement in the new process. Additionally, the office managers at
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each clinic assisted in scheduling, setting up, and providing lunch for the educational
sessions at each clinic. Another facilitator for this objective included the level of
engagement of the providers at the practice. During the educational sessions, many
providers expressed excitement and support of the new process as well as with closer
adherence to the evidence-based guidelines. Finally, the availability of a robust EHR
system, as well as an EHR specialist to assist with the project and report build in order to
complete chart audits, were significant facilitators in evaluating objective one.
Barriers. Limitations to the data collection for evaluation of Objective one did
exist. The primary limitation is the small sample size for the survey response. This small
sample size limits the data analysis that can be done and the inferences that can be made
based off of that analysis. In order to prevent identification of providers who completed
the survey, survey responses were presented in aggregate form and did not include
identifying information. This limited the analysis of the data by making it impossible to
compare pre- and post-survey findings of the same provider. Also, there was no way of
identifying whether providers who responded on the post-intervention survey had
actually attended the educational session.
Additionally, provider comments in the survey indicated a lack of understanding
of some of the questions such as references to annual pelvic exams and sexual transmitted
disease screening when being asked about cervical cancer screening. Some providers
partially answered the screening and follow-up questions by answering what the followup should be but not the interval that it should be done in. In these cases, these scenarios
were marked as correct if the appropriate testing was identified.
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For the chart audits, the primary limitation is the strength of the documentation.
The researcher relied on prior pathology, infectious disease, health maintenance, and
provider documentation to determine when the appropriate follow-up should be. If the
provider was using information not documented in one of these places to determine
appropriate screening follow-up, the audit may not accurately reflect the appropriate
follow-up interval due to information unknown to the researcher. Additionally, for
Question two, the researcher marked the chart as a no if the current screening was done at
an incorrect interval regardless of the reason. Different reasons noted included lack of
follow-up by the patient, inappropriate screening interval chosen by the provider, change
of patient between practices, and patient requests for a different screening interval.
While this project did show an improvement in provider guideline adherence, it
cannot be distinguished whether this improvement was a result of the educational session
or the implementation of the notification, tracking and reminder system. The use of a
smart phrase within the EHR that has pre-populated text and includes a default follow-up
based on the guidelines for normal screening results as well as the educational session,
both could have resulted in this improvement in follow-up recommendations found.
There are also barriers, or limitations, of the ASCCP guidelines themselves that
impact the provider’s ability to adhere to the guidelines. These guidelines rely heavily on
past results in order to determine an appropriate screening interval. These results may be
unavailable or may be given to the provider second hand from the patient without all of
the necessary information known in order to make an accurate follow-up
recommendation. Additionally, prior cases of failure to follow up can impact the current
decision making such as a patient failing to follow up and then being seen in clinic when
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they are overdue for repeat screening. Question two, which asks whether the current
screening was done at an appropriate interval from the last screening, was marked as no if
the screening did not occur at an appropriate interval for any reason. This finding could
have been due to patient non-compliance with follow-up recommendations or provider
non-compliance with the guidelines and was not specified during data collection. This
limits the interpretation of these data.
Objective Two
This objective was more difficult to evaluate statistically than Objective one. The
survey questions designed to evaluate provider knowledge of the notification, tracking
and reminder system all remained the same or improved following the roll out of the new
system. Again, sample size limits the ability to apply this finding to a broader audience.
Additionally, more research would need to be done to identify whether knowledge of,
and confidence in the practice’s tracking and reminder system improves outcomes.
The chart audits were done in order to evaluate compliance with the overall
process. Slightly over one-quarter of the charts were not done correctly by the provider
according to the process. If a provider missed the educational session, they were given
the tip sheet and assisted with setting up their EHR short cuts by the nurse manager
following the educational session. Additionally, there was a report built into the nursing
process for the Pap pool that caught charts that were done incorrectly and ensured that
they didn’t fall out of the new system. If a chart was identified that was done incorrectly
by the provider, the provider was then contacted and reminded of the new process and the
necessity of its use. Therefore, some providers were noted to do the process incorrectly
initially and then begin doing it correctly, indicating they had received the education.

55
Further audits may identify that the provider compliance with the process increases over
time.
Facilitators. The primary facilitator for this objective was the practice’s robust
nursing leadership team. They, in conjunction with the provider champions, assisted in
development and design of the tracking and reminder system in order to ensure that it
was feasible within the current resources and structure of the practice. Additionally, the
support of the EHR specialist was instrumental in designing this process.
Barriers. The primary barrier to this objective was a lack of EHR build support.
The practice has an EHR specialist who assisted with report writing, networking, and
EHR functionality questions and served as a valuable resource during creation of the
project. In order to build a new process into the EHR, however, the support of someone
who is able to build functionality in was necessary. Build analysts for the EHR for this
practice were shared with another large healthcare organization, which limited their
availability to incorporate requested changes and answer questions as they arose,
extending the length of the project overall.
Another barrier to this objective was that some providers had already developed
their own system for notification, tracking and reminding for cervical cancer and were
hesitant to change to the new process. Providers were provided the opportunity to ask
questions and given contact information in case they identified any opportunities for
improvement with the new process. Additionally, the medical director sent an e-mail in
support of the new process to all providers.
The final barrier to implementation of this system was the time and resources
necessary to manage the Pap pool. Throughout the design of the system, extensive
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discussion occurred regarding who would be best to manage the pool and whether a
smaller group of nurses should pilot running it. Ultimately, this was decided to be the
most feasible approach, and the nurse managers were identified as the group to run it.
Practices looking to implement similar notification, tracking and reminder systems need
to look at their current support staff availability and determine whether they have the
resources necessary to successfully implement this type of process. For each result sent to
the Pap pool, it takes the nurse approximately 10 minutes to complete the notification and
enter the patient into the Pap pool system. Additional time will be required as the patient
follow-up reminders begin to appear, estimated at 10 minutes per reminder.
Unintended Consequences
An unintended consequence of this project included increased work for nursing
staff at the practice. While the new process is streamlined and more efficient than the
prior process, the new project involves mailed notification for normal results as well as
abnormal results. This was supported as best practice by the evidence but does increase
the workload of the nursing staff (Slone et al., 2015). The workload and documentation
for providers has not increased with this project, and for some providers may have
decreased the amount of time it takes them to follow up on results of cervical cancer
screening.
Recommendations
Notification, Tracking and
Reminder System
The recommendation of the researcher is that this quality improvement project be
continued and possibly expanded. The literature supports the need for an effective patient
notification, tracking and reminder system as well as a need for improved support for
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provider compliance with the guidelines. Use of features in the EHR such as point-ofcare reminders and patient reminders has been shown in other research to increase
guideline compliance (Dupuis et al., 2010; Langsjoen et al., 2015; Shojania et al., 2011).
While specific system features were not evaluated in this project, the recommendation
would be to continue the new process that was developed and expand by possibly
collecting longer term data on patient and provider guideline adherence.
In discussion with nursing leadership and several providers, there seems to be a
benefit to using a select nurse pool to manage quality improvement initiatives in areas
such as cervical cancer screening. As the practice continues to grow, and with the focus
of reimbursement focusing on quality of care indicators, there may be room in the future
to expand the role of this nurse pool to include other screenings and quality measures.
This would be done as a collaboration between providers and nursing, and the process
designed for this project could be used as a template with modifications made for the
specific initiative being managed.
Provider Education Session
From the research findings, it is unclear whether the educational session was
effective and should be continued or replicated at other practices. Increased provider
guideline adherence provides an evidence-based approach to care and decreases the
number of unnecessary procedures that are done, reducing cost of both time and money
and lessening the risk of psychological distress to the patient from having the procedure
done (Cox, 2009; O’Connor et al., 2015). Further research on effective educational
strategies and methods to improve provider guideline compliance would be beneficial.
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Congruence with Organization Objectives
Continuing this new system aligns with the practice’s strategic model as a patient
centered medical home by providing a consistent, evidence-based approach to cervical
cancer screening and communication with both providers and patients. It allows for
notification of patients to occur in a manner that has been demonstrated in the review of
the literature to improve patient understanding of the follow-up recommendations and
increases compliance with those reccomendations. Additionally, the tracking and
reminder system gives the practice a well-designed tool for managing these complicated
guidelines.
Project Outcomes within the Theoretical Framework
Use of the Donabedian framework for quality improvement was found to be
particularly useful for this project. The three components of Donabedian’s theory are
outcomes, structure, and process (Donabedian, 2005). For the scope of this project,
patient outcomes were not evaluated. Extensive research already exists regarding the
outcomes of use of the screening guidelines (Cox, 2009). The process component of this
project focused on the provider knowledge and behaviors. There was not found to be a
substantial change in this component of the quality improvement model. The final
component, structure, is where this project was most impactful through implementation
of the notificaiton tracking and reminder system. Implementation of an electronic
process, such as this, serves to improve the structural aspects of how care is provided at a
practice.
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Implications for Future Research
The second chart audit looked at whether the current screening was done at a
correct interval from the prior screening. In collecting this data, cases of follow-up that
did not comply with the guidelines were not delineated by fallouts due to provider or
patient non-compliance, so future research would be beneficial to evaluate only those
fallouts that occurred due to provider non-compliance. Additionally, there are many
reasons for the inaccurate follow-up. The provider may have been acting on a prior result
note that indicated an improper screening interval when deciding whether to screen the
patient or not at the current visit. They may also be screening more or less frequently due
to patient request.
Further research should be done to identify whether the identification of the
correct follow-up interval, the first question for chart audits, would lead to longer term
improvements in this second item being audited in the future. As the patient visits for
future annual examinations and visits, the provider will see the prior result note with the
correct recommendation and may be more likely to start completing the screening at an
appropriate interval. For the scope of this project, charts were only audited to identify
whether or not the recommendation or screening fell within the guidelines. It would be
beneficial for additional research to be done to identify if there are specific screening
findings or specific populations that are more likely to have an inappropriate follow-up
done to assist in determining where best to focus future quality improvement initiatives.
Finally, the educational session was created based on a history of cervical cancer
screening, a review of evidence supporting the guidelines, and the risks of poor guideline
adherence. Further research could be done to identify which components of an
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educational session are more likely to improve guideline adherence. Additionally,
presenting this educational session separately from the roll out of the new system may
have improved the efficacy of the educational session. Discussion about the new process
may have distracted providers during the educational session.
Ongoing Evaluation
Ongoing evaluation that will need to be continued outside of the scope of this
project will be monitoring provider and nurse compliance with the notification, tracking
and reminder system that was designed and implemented. The use of the report that the
nurses will be compiling will serve to monitor provider compliance with the process. As
the process continues to be used, there will likely be identified areas of improvement for
ease of use or efficiency. The nurse educator, who was instrumental in providing insight
into the process design and assisting with the roll out, will continue to manage the Pap
pool and assist with any modifications to the process as necessary. There may be a need
to expand the number of nurses who manage the Pap pool. The nurse educator, along
with the nurse managers, will expand the pool and provide additional training as
necessary in order to keep the workload at a manageable level.
Application to Other Settings
This project is very applicable to other primary care practices as well as other
medical disciplines such as gynecology practices. The notification, tracking and reminder
system, as well as the educational session, could be replicated and implemented within
the framework of additional medical care settings. The chart review and survey process
could also be replicated to identify both process and structure gaps in the management of
cervical cancer screening as well as other types of screenings or medical management of
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certain conditions. Additionally, there exists a plethora of guidelines within healthcare.
These guidelines have been created by experts in the field and are based off of evidence
available regarding the most effective screening and treatment strategies. The findings of
this project could be used to help identify and create further research and interventions
aimed at improving compliance with other guidelines in practice.
Reflections
Through completion of this project, the researcher learned valuable lessons
regarding creation and implementation of quality improvement initiatives. This included
developing a project idea, completing an extensive review of the literature to determine
the evidence-based intervention that will be used, developing a data collection plan,
engaging stakeholders, process implementation, and analyzing results.
In regard to creating a research project and plan, the data collection portion
provided the greatest learning opportunity for the researcher. The survey, while a
modified version of a validated national survey, required the student to anticipate the
information that would be needed to effectively evaluate the objectives identified. The
student learned that surveys, while easy to build and distribute to a large number of
participants, can be complicated to develop. Questions and options need to be worded in
a way that the risk of an incorrect interpretation of any of them does not invalidate the
results. Additionally, analyzing and interpreting the data also presented a great learning
opportunity for the student who, prior to this project, had limited experience with this
portion of project planning and implementation.
Finally, as a student preparing to enter practice, the most influential learning that
occurred was direct observation of and conversations with numerous providers about the
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use of guidelines in clinical practice. The consistent use of evidence-based guidelines
gives providers the tools to provide high quality care to their patients and decreases
liability on the part of the provider. There are numerous evidence-based guidelines and
the research is constantly changing. As a provider, it is important to stay abreast of
changes to guidelines and new research as it comes out in order to provide the highest
quality care to patients. The use of resources and tools that are provided, such as the
ASCCP application that the student recommended providers use, give the providers
additional support and resources allowing them to practice efficiently and effectively.
The student has observed and participated in care but has not directly provided
unsupervised independent care in practice. Learning to develop and implement a process
for which the student did not have extensive prior experience in presented some
challenges. The guidance of the research committee as well as nursing and support staff
at the practice were instrumental in the successful implementation of this project.
The student’s current role as a nurse is in nursing leadership. This involves the
analysis of problems and implementation of projects and interventions to address these.
This experience served the student well in creating this project; however, key differences
between implementation of a project at the nursing and provider levels were highlighted.
The providers at this practice are passionate about, and take a lot of pride in, caring for
their community and patients well. Medicine is both a science and an art and each
provider has used their experiences to refine their craft. This project addressed the
science of patient care; however, the art of it lies in conversations with patients, risk
versus benefit discussions, and shared decision making that takes into consideration that
not all patients fit perfectly into algorithms and guidelines. This, the art of advanced
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practice nursing, is what is learned through experience and what the student will strive to
hone after completion of this project and entry into practice.
Essentials of Doctoral Education for
Advanced Nursing Practice
The American Association of College of Nursing (2006) delineated eight
competencies that they deem essential components of a Doctor of Nursing Practice
(DNP) degree. These components are found throughout DNP programs curricula as well
as throughout the course of completion of the DNP Scholarly project as the final
requirement of the degree. The following section outlines the eight DNP essentials in the
context of the completion of this quality improvement project.
The Essentials I through III focus on the preparation of the student to practice in
an evidence-based manner, identify and implement processes to improve quality of care,
and pursue the development of new research. Through the development of the project
plan, the student was able to integrate of these essentials into practice. The American
Association of Colleges of Nursing (2006) stated the student will, “Use science-based
theories and concepts to . . . describe the actions and advanced strategies to enhance,
alleviate, and ameliorate health and health care delivery phenomena as appropriate” (p.
9). This was achieved through identification of the need to evaluate provider guideline
adherence as well as the need for an improved notification, tracking and reminder system.
Partnering with key end users in the organization, such as the nurse managers, allowed
the student to exercise leadership and project management skills. Completion of the
review of the literature and evaluation of the current state of practice, indicate the
student’s ability to fully analyze an identified problem, complete a gap analysis, design a
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project aimed at improving quality of care, and collect outcomes data to evaluate the
effectiveness of the project.
Essential IV focuses on the use of health information technology to assist in
driving quality care. The EHR was a large component of this project, and the student
gained a lot of experience in the benefits and limitations to the use of the EHR for quality
improvement. Essential IV states that “Demonstrate the conceptual ability and technical
skills to develop and execute an evaluation plan involving data extraction from practice
information systems and databases” (American Association of Colleges of Nursing, 2006,
p. 13). Through the creation of the chart audit report and completion of chart audits, the
student was able to demonstrate this Essential component. Additionally, implementation
of the new process into the EHR allowed the student to become more familiar with EHR
functionality and ability to improve efficiency, quality, and safety when used to its fullest
potential (Sullivan & Smolowitz, 2013).
Essentials V, VI, and VIII focus on the student’s ability to demonstrate
interprofessional collaboaration, advocacy in health care policy, and advanced practice
nursing. Throughout this project, the student was involved with many people in many
positions and roles throughout the practice. Initially, the student met with the nurse who
was managing the current system to evaluate what was in place and what gaps had
already been identified. Following the review of the literature, the student met with
provider leadership and nursing leadership several times to discuss the literature review
findings and suggested project plan. The office managers were involved in assisting with
scheduling the educatioanl sessions at each office. Additionally, the student met with the
EHR specialist multiple times to evaluate and create EHR functionality. Implementation
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of this project required input and collaboration from multiple members of the healthcare
team in order to create a robust, evidence-based process to serve the practice’s clients.
This new process required a new workflow for providers and nurses, changing the policy
of the way care is provided at the practice. Finally, analysis of the quality improvement
data findings and synthesization of this information into practice implications became the
culmination of the experience for the student. The DNP student was able to complete this
project from start to finish, effectively learning and demonstrating competency in
practicing nursing at an advanced level.
The final essential described is Essential VII, regarding clinical prevention and
population health. These two components of healthcare are essential if the healthcare
community is to continue to drive forward improved overall health and quality of life.
Prevention, and focus of improved health on populations within the community, is the
cornerstones of primary care practice. This project incorporated both prevention and
population health considerations through the focus on guideline adherence.
The development and completion of this project allowed the DNP student to not
only observe, but to be integrally involved in, what it means to continue to strive for both
process and quality improvement in practice. The DNP degree is the terminal degree for
nursing (American Association of Colleges of Nursing, 2006). “They [practice-focused
doctoral programs] focus heavily on practice that is innovative and evidence-based,
reflecting the application of credible research findings” (American Association of
Colleges of Nursing, 2006, p. 3). Through completion of this project the student was able
to gain experience in how to drive this type of care, innovative and evidence-based, and
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was allowed the opportunity to successfully demonstrate competency of all Essential
elements of the DNP.
Conclusion
Despite limitations to this study, such as sample size that limit assumptions that
can be made on the data, the new process served to address the need for implementation
of a more efficient and sustainable notification, tracking and reminder system. This
system is important in ensuring that patients receive proper screening for cervical cancer
that achieves a balance between early identification of potential neoplasm and
unnecessary testing or procedures done. It is also extremely important for organizations
to have processes in place to notify, track, and remind their patients to follow up on any
abnormal findings in order to continue to drive down mortality associated with cervical
cancer.
Following implementation of this quality improvement project, providers were
much more likely to correctly recommend follow-up to their patients after receiving their
cervical cancer screening results. This improvement, however, did not necessarily
correlate with practice as they were not any more likely to actually screen their patients at
an appropriate interval post-intervention. Additionally, the survey findings indicated a
slight improvement in provider guideline adherence on a series of patient scenarios. The
small sample size limits the ability of these findings to be relied on for replication,
however, does indicate that in this population there was a slight improvement.
Additionally, the Pap pool was found to be an effective tool for notification,
tracking and reminder systems as they were 100% compliant in chart audits following Go
Live of the new process. Provider compliance was not as consistent; however,
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consistency is expected to improve as they become more familiar with the new system.
Practices looking to improve provider guideline adherence and their structural approach
to management of cervical cancer screening should consider implementation of a similar
process.
Following this project from initiation to completion gave the researcher valuable
insight into the Essential elements that are expected to exist in all DNP curricula. While
all eight elements were found throughout this project, particularly implementation of
evidence-based practice and quality improvement were highlighted. Donabedian (2005)
stated, “One is interested not in the power of medical technology to achieve results, but in
whether what is now known to be ‘good’ medical care has been applied” (p. 694). Good
medical care is that which, to the best of the provider’s ability, is based off of what
current evidence supports as best practice for improving quality of care provided and
overall health outcomes for patients.
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Note. From “Cervical Cancer Screening: Evidence Behind the Guidelines,” by B. F. Lees,
B. K. Erickson, and W. K. Huh, 2016, April, American Journal of Obstetrics &
Gynecology, p. 439.
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Table 7
Literature Review Matrix
Article title

Authors

Year of
publication

Type and level
of evidence

Notes/ Findings/ Findings

Adherence to the 2012 National
Cervical Cancer Screening
Guidelines: A Pilot Study

Teoh, D. G., Marriott, A. E., Vogel, R. I,,
Marriott, R. T., Lais, C. W., Downs Jr., L. S.,
Kulasingam, S. L.

2015

Cross sectional
survey/ Level
VI

Survey of providers to determine knowledge of updated (3 years prior)
cervical screening guidelines; Efforts should focus on improved provider
and patient education, and methods that facilitate adherence to the
guidelines such as electronic health record order sets.

Current Practice Patterns in Cervical
Cancer Screening in Indiana

King, N. R., Kasper, K. M., Daggy, J. K.,
Edmonds, B. E.

2014

Survey/ Level
VI

Vignette based survey. Most providers report following 2012 guidelines,
however, many continue to screen more frequently than indicated.

Discontent and Confusion: Primary
Care Providers' Opinions and
Understanding of Current Cervical
Cancer Screening Recommendations

Boone, E., Lewis, L., Karp, M.

2016

Survey/ Level
VI

Assessed provider's perceptions of updated guidelines. Findings: Distrust
and confusion exist, leading to lack of compliance with guidelines and
unnecessary screening and testing.

Does a 30-min Quality Improvement
Clinical Practice Meeting Reviewing
The Recommended Papanicolau Test
Guidelines for Adolescents Improve
Provider Adherence to Guidelines in a
Pediatric Primary Care Office?

Lozman, R. L., Belcher, A., Sloand, E.

2011

Quality
Improvement
Project/ Level
IV

Provided an educational session at peds primary care office. After, saw
significant decrease in unnecessary Paps and overall increased guideline
compliance.

Electronic Health Records and
Ambulatory Quality of Care

Kern, L. M., Barron, Y., Dhopeshwarkar, R.
V., Edwards, A., Kaushal, R.

2012

Cross Sectional
Study/ Level IV

Observes the effects of EHR implementation on screening practices across
several screening modalities

Improving Compliance with Cervical
Cancer Screening Guidelines.

Langsjoen, J., Goodell, C., Castro, E.,
Thomas, J., Kuehl, T., Wehbe-Janek, H.,
Hinskey, M.

2015

Quality
Improvement
Pilot/ Level IV

Implemented point of care reminders in EPIC and an educational session
for providers. Greatest improvement with HPV co-testing was noted in
family practice.

Provider Attitudes and Screening
Practices Following Changes in Breast
and Cervical Cancer Screening
Guidelines

Haas, J, S., Sprague, B. L., Klabunde, C. N.,
Tosteson, A. N., Chen, J. S., Bitton, A.,
Beaber, E. F., Onega, T., Kim, J. J.,
MacLean, C. D., Harris, K., Yamartino, P.,
Howe, K., Pearson, L., Feldman, S.,
Brawarsky, P., Schapira, M. M.

2015

Survey/ Level
VI

Self-reported attitudes of providers via survey were assessed. Top reported
barriers included patient perceptions, provider's disagreement with
guidelines, performance based measures that conflict with guidelines,
concern about liability, lack of time to discuss less frequent screening with
patients.
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Table 7 (continued)
Article title

Authors

Year of
publication

Type and level
of evidence

Notes/ Findings/ Findings

The Effects of On-Screen, Point of
Care Computer Reminders on
Processes and Outcomes of Care

Shojania, K.G., Jennings, A., Mayhew, A.,
Ramsay, C.R., Eccles, M.P., Grimshaw, J.

2011

Literature
Review Level
V

Literature review of studies looking at the impact of point of care
reminders on provider behavior. Small to modest improvements were
found utilizing point of care reminders.

Cancer Screening Reminders:
Addressing the Spectrum of Patient
Preferences

Brandzel, S. D.; Aiello Bowles, E.
J.,Weineke, A.,; Bradford, S. C., Kimbel, K.,
Gao, H., Diana S.M.

2017

Focus Group/
Level VI

Assessed patient reminder preferences. Findings: Patients preferred
personalized reminders and individually (not summary report annually) no
more than three months prior to due for repeat screening.

Inadequate Systems to Support Breast
and Cervical Cancer Screening in
Primary Care Practice

Schapira, M. M., Sprague, B. L., Klabunde,
C. N., Tosteson, A. N., Bitton, A., Chen, J.
S., Beaber, E. F., Onega, T., MacLean, C. D.,
Harris, K., Howe, K., Pearson, L., Feldman,
S., Brawarsky, P., Haas, J. S.

2015

Survey / Level
VI

Focused on PCMH. Found that a lack of system support for screening for
breast and cervical cancer exists. Looked specifically at clinical decision
support, comparative performance reports, lack of an automated report
system for patients overdue for screening, and lack of report of patients due
for follow up.

Inconsistencies Between Medical
Records and Patient-Reported
Recommendations for Follow-Up
After Abnormal Pap Tests

Slone, S., White, C. W., Shelton, B., Van
Meter, E.; DeSimone, C. D., Schoenberg, N.,
Dignan, M.

2013

Survey / Level
VI

Survey of patients understanding of follow up recommendations compared
with actual recommendations Results: The most misunderstood directions
were those that required gynecology follow-up or were more severe.
Limitations- Done in rural Appalachia

Pap Hub: A System to Improve
Compliance with Pap Smear
Screening Guidelines in a Large
Healthcare System

Teoh, D. G., Fall, L. A., Beitelspacher, E. A.,
Lais, C. W.

2014

Quality
Improvement
Project/ Level
VI

Implemented a centralized pap hub that monitored results and sent
notification and reminders. Nurses triaged normal results and provider did
any abnormals.

Patient Notification of Test Results in
a Primary Care Setting

Sullivan, C., Smolowitz, J.

2013

Retrospective
Review/ Level
VI

Notification of both normal and abnormal test results should occur. Study
found variation in methods used to notify patients and follow-up.

Tracking Abnormal Cervical Cancer
Screening: Evaluation of an EMR
Based Intervention

Dupuis, E. A., White, H. F., Newman, D.,
Sobieraj, J. E., Gokhale, M., & Freund, K. M.

2010

Pretest/
posttest/Level
IV

Created a report that was generated monthly showing patients who had not
followed up. Significantly decreased the average time to diagnostic
resolution.
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Table 7 (continued)
Article title

Authors

Year of
publication

Type and level
of evidence

Notes/ Findings/ Findings

Tracking and Reminder Systems

The American College of Obstetrics and
Gynecologists

2012

Committee
Opinion/ Level
VII

Committee opinion on the need for, and reasons behind, an effective
tracking and reminder system

Making Healthcare Safer: A critical
analysis of patient safety practices

University of California at San Francisco
(UCSF)–Stanford University

2001

Literature
Review/ Level
V

A report prepared for the AHRQ on safety practices. Section on critical
results communication and follow up.

Note. This table demonstrates articles included in the literature review regarding provider adherence to guidelines and patient
notification, tracking and reminder systems.
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Cervical Cancer Screening Survey
Thank you for taking the time to take this survey. This survey was designed to collect
data for a quality improvement project and was adapted from the AHRQ and CDC’s
“National Survey of Primary Care Physicians’ Cancer Screening Recommendations and
Practices”. Results are confidential and will be aggregated with other providers’
responses. Participation is voluntary but greatly appreciated.
Survey Instructions:
 Several questions are multiple choice.
 Please mark the box of the corresponding answer that best fits your current
clinical practice.
 Assume all patients are otherwise healthy individuals with no history of
immunocompromise or increased risk unless specified in the scenario.

Part A: Provider Demographics
A1. Degree (SELECT ONE)
 MD/ DO
 PA
 NP
A2. Age in years (SELECT ONE)
 Less than 35
 35-50
 >50
A3. Sex (SELECT ONE)
 Female
 Male
A4. Years in practice (SELECT ONE)
 <5
 5-10
 > 10 years
A5. Approximately what percentage of your patients in your main primary care practice
is: (YOUR BEST ESTIMATE IS FINE)
a.
b.
c.
d.

Under 18___________%
18-39 ______________%
40-64______________%
65+ years__________%
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A6. Approximately what percentage of your patients in your main primary care practice
is female? (YOUR BEST ESTIMATE IS FINE)
a. Female ____________%
A7. During a typical year, for how many asymptomatic, average-risk female patients do
you personally order or perform cervical cancer screening with Pap testing and/ or HPV
testing? (SELECT ONE)

 1-10
 11-20
 > 20
Part B: Process
B1. How effective do you believe the following screening procedures are in reducing
cervical cancer mortality in average-risk women?
Very Effective

Pap test (liquid
based cytology,
e.g., Thin Prep®
or SurePath®)

HPV DNA test
with Pap test
HPV Testing as
primary
screening
(without
simultaneous
Pap test)

Somewhat
Effective

Not Effective

Effectiveness
Not-known
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B2. In your clinical practice which cervical cancer screening guidelines do you follow?





American Society of Colposcopy and Cervical Pathology (ASCCP)
United States Preventative Taskforce Services (USPTS)
American College of Obstetricians and Gynecologists (ACOG)
Other:_______________________________________

B3. Assume that the following female patients present for a routine visit in your office.
What would you be most likely to recommend for cervical cancer screening at this visit?
Patient
Scenario

Procedure

Interval

18-year-old
who had
sexual
intercourse
for the first
time 1 month
ago and is
presenting
for her first
gynecologic
visit













18-year-old
who first had
sexual
intercourse 3
years ago
and is
presenting
for her first
gynecologic
visit







Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________

Annually
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________

Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________
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21-year-old
who has
received the
entire HPV
vaccine
series







Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________
25-year-old
who has no
history of
abnormal
Pap smears







Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________
35-year-old
who has had
3 consecutive
negative Pap
tests
performed
by you







35-year-old
whose cervix
was removed
last year
during
hysterectomy
for
symptomatic
fibroids







Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________
Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________
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Healthy 66year-old who
has had 3
consecutive
negative Pap
tests
performed
by you. The
last was a cotest three
years ago
which was
negative for
HPV as well.







Healthy 66year-old who
has not had
routine
screening for
cervical
cancer since
her mid- 30’s







Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________

Pap
Pap + HPV testing
HPV Testing alone
None
Other:_____________________







Annual
Every three years
Every five years
None
Other:___________________

______________________________ ____________________________

B4. You receive the following results on the following patients. What is your follow-up
recommendation?
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Patient

Follow-up Testing

Interval

21-year-old
with result
of ASC-US
with no
prior
screening













Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________

Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________

22-year-old
with results
of LSIL
with no
prior
screening







Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________







Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________

25-year-old
with result
of ASC-US
with prior
negative
Pap







Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________







Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________

31-year-old
with result
of negative
cytology
and HPV,
prior result
LSIL







31-year-old
with result
of negative

 Repeat Pap cytology
 Reflex HPV testing
 Pap + HPV testing

Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________







Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________
 Immediate
 One year
 Every three years
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cytology
and HPV,
prior result
LSIL

 Colposcopy
 Other:_____________________

35-year-old
with
negative
cytology
but positive
HPV test:
HPV 16
and 18
negative







 Every five years
 Other:___________________

______________________________ ____________________________

Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________







Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________

38-year-old
with LSIL
and
negative
HPV test

42-year-old
with a
result of
ASC-US
and HPV
negative,
prior result
cytology
negative,
HPV
positive







Repeat Pap cytology
Reflex HPV testing
Pap + HPV testing
Colposcopy
Other:_____________________







Immediate
One year
Every three years
Every five years
Other:___________________

______________________________ ____________________________
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B5. Are you following current screening guidelines on all of your patients? If no, why
not? (SELECT ALL THAT APPLY)








I am following current screening guidelines
I do not know the current guidelines
I do not think guidelines are based on good data
I believe I have a higher-risk population
My patients are requesting more frequent screening
I am worried about missing high grade dysplasia or cancer in the interim
I am worried about being able to keep track of whether my patients complete
follow-up with a longer screening interval
 Other:
__________________________________________________________________
__________________________________________________________________

Part C. Structure
C1. Does your practice have a mechanism to remind you or other members of the care
team that a patient is due for breast or cervical cancer screening? (SELECT ALL THAT
APPLY)







Yes, special notation or flag in patient’s chart
Yes, computer prompt or computer-generated flow sheet
Yes, I routinely look it up in the medical record at the time of a visit
Yes, other mechanism (specify): ____________
No
Don’t Know

C2. Does your practice have a mechanism to remind your patients that they are due for
cervical cancer screening? (SELECT ALL THAT APPLY)
 Yes, verbal prompt from you or another member of the care team during an office
visit
 Yes, reminder by Mail
 Yes, reminder telephone call
 Yes, reminder by e-mail
 Yes, other mechanism (specify): ____________
 No
 Don’t Know
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C3. Do you use any of the following resources for managing cervical cancer screening in
practice? (SELECT ALL THAT APPLY)








Printed Guidelines
Website
Phone or tablet application
Patient Handouts
Other:________________________________________________________
None of the above

C4. Does your practice have a system to track patients who do not complete follow-up of
an abnormal screening result? (SELECT ONE)
 Yes
 No
 Not Sure
C5. Does your practice have a mechanism to inform patients of abnormal results?
(SELECT ALL THAT APPLY)







Yes, letter by US Mail
Yes, telephone call
Yes, email message
Yes, other method: ___________________________
Don’t know
No

Is there anything else you would like to mention about breast or cervical cancer screening
in your practice or in general?

Note: Survey adapted from the AHRQ and CDC’s “National Survey of Primary Care
Physicians’ Cancer Screening Recommendations and Practices
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Provider Educational Session Outline
Part 1: Educational Session (20 minutes)
1) Cervical Cancer Screening History
a. Cervical Cytology
b. HPV Genotyping
c. 2012 ASCCP Guidelines
2) Risks of Over Screening
3) Findings from literature review regarding guideline adherence
a. Guideline Compliance
b. Use of the EHR
c. Notification
d. Tracking and Reminder Systems
4) Review of practice survey findings
5) Guideline Resources

Part 2: Training on New System (20 minutes)
1) Review of structure of new system and expectations
2) Review and assist with setting up quick actions for routing result notes to the Pap
pool

Note: Outline of the information presented during the provider educational sessions.
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Chart Audits for Cervical Cancer Screening

All patient records will be kept confidential and will not leave the property of the
practice. No patient identifiers will be recorded or used nor will date of service.
Individual testing results and diagnosis will not be included. Internal Review Board
review and approval will be obtained as necessary per university and facility guidelines.
The student is current with, and will remain throughout the duration of the project,
Confidentiality Training. The student will retain all information extracted from the chart
reviews in a secure site within AFM’s electronic network. No information will be
transferred to a thumb drive or other external storage, and no paper information will leave
AFM offices. The information presented in the capstone project paper will not include
any patient health information that could potentially identify a patient.
Adherence (pre and post data)
1) Did recommended follow-up comply with either the preferred or acceptable
options per the 2012 ASCCP Guidelines? (Use of the updated 2015 guidelines for
primary HPV screening alone will be accepted as well)
a. Yes
b. No
2) If available, did screening interval from last screening comply with the 2012
ASCCP Guidelines? (Use of the updated 2015 guidelines for primary HPV
screening alone will be accepted as well)
a. Yes
b. No

Process (post data)
3) Was a result note placed and routed to the PAP pool?
4) Was a tickler placed in the patient’s system?
5) Was a notification letter sent to the patient?

Note: Chart audit form for project evaluation.
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Dear Provider,
My name is Amanda Miller DNP-S, BSN, RN. I am a Family Nurse Practitioner student
at the University of Northern Colorado, pursuing a Doctor of Nursing Practice (DNP)
degree. I have been working with Dr. Stephens and Dr. Klingner to conduct a quality
improvement project on the management of cervical cancer screening in primary care.
Participation in this DNP project involves completing confidential online surveys. The
surveys will be confidential and unidentifiable to protect your privacy. The survey will
take approximately 20-30 minutes to complete and will consist of multiple choice, select
all that apply, and one free text question. You will have two weeks to complete the
survey. Part of my project involves implementation of an electronic patient notification,
tracking and reminder system for cervical cancer screening. Following implementation of
this process and an optional educational session, a repeat survey will be sent following
the same process as the first.
Responses from this survey will remain confidential and will be used solely for the
purpose of this study. Participation in the study is voluntary and you may withdraw
participation at any time without penalty. Participants who complete the survey will be
entered into a drawing for one of five $10 gift cards. This drawing will be completed
following both the pre and post implementation surveys. Once you complete the survey,
please notify your office manager to place your name on the list for the gift card drawing.
There are no foreseeable risks that have been identified in the participation of this quality
improvement project. Submission of this survey means that you are consenting to the
participation in this project.
This quality improvement project has been reviewed by the University of Northern
Colorado Institutional Review Board and has been deemed acceptable in meeting the
requirements intended to protect the rights and wellbeing of its participants.
Survey link: https://unco.co1.qualtrics.com/jfe/form/SV_1X4hEktdDPVnWFn
Should you have any questions or concerns please contact Amanda Miller at
huff1824@bears.unco.edu or the Research advisor Dr. Jeanette McNeill at
Jeanette.mcneill@unco.edu.
Thank you for your time and consideration.
Respectfully,
Amanda Miller, DNP Candidate
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Statement of Mutual Agreement
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Note: Memorandum of understanding between the student and the clinical site for the
DNP project.

